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CLARENCE S. LIVINGOOD, M.D.
It is a great honor for me to address the membership of this society and its
guests in my role as President.
All of us have reason to be proud of this society; in a brief span of 16 years
it has reached a stature which is comparable to that of older similar organiza-
tions in other fields of Medicine and Surgery. The program for this meeting in-
cludes 34 papers; 17 institutions are represented; all but one of the senior essayists
are dermatologists or basic scientists associated directly with Dermatology de-
partments. In reading the abstracts of these papers, one is impressed by the
wide range of basic science disciplines which are represented.
The perusal of the proceedings of this society, as well as a review of the Derma-
tology journals, makes it obvious that during the last decade the volume of basic
science investigative work, directly related to problems of the skin, has increased
by leaps and bounds. I have not conducted a survey, but one would be conserva-
tive in estimating that the number of Dermatology departments in this country,
in which basic investigative work is conducted on a significant scale, has increased
many-fold. Without difficulty, I could name at least 15 or 20 men with previous
training in one of the basic sciences who have entered the ranks of Dermatology
during the past 10 years. The stimulus of their teachers and opportunity to work
with basic scientists, have led others to acquire a significant degree of proficiency
along these lines during their fellowship and residency training periods. The
caliber of this program year after year is an impressive testimonial to the vital
past and still growing interest in basic investigation as it relates to our specialty.
It exemplifies the great desire of a constantly increasing number of dermatologists
to make basic contributions to the etiology and treatment of skin diseases. As
long as this trend continues, one can look forward to the future with the anticipa-
tion that our understanding and control of skin diseases will continue to become
more satisfactory.
The subject for discussion today was selected because I believe that it is the
obligation of this Society to foster superior clinical research as well as basic
research. Let us define clinical research. The word "research" means "difigent
protracted investigation, especially for the purpose of adding to human knowl-
edge; studious inquiry." Clinical is derived from the Latin "clinicus" meaning
"bedridden person." Therefore, the literal meaning of clinical research is "a
studious inquiry of bedridden people (1)." Dermatologists, in particular, are
justified in liberalizing this definition to include ambulatory patients. To this
literal definition of clinical research must be added: the concomitant utilization
of the laboratory, scientific experimental planning, appropriate use of controls,
and proper statistical analysis of data. The important role of good dermatologic
* From the Division of Dermatology, Henry Ford Hospital, Detroit, Michigan.
Read before the Sixteenth Annual Meeting of The Society for Investigative Derma-
tology, Inc., Atlantic City, N. J., June 4, 1955.
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clinical research in advancing our knowledge regarding the etiology and treatment
of skin diseases, in increasing the stature of our specialty, and in improving the
training of specialists in Dermatology (as well as undergraduate students) is
self evident.
Too frequently, claims regarding the effectiveness of new and old therapeutic
agents are based on clinical experience rather than scientific clinical investigation.
In this connection, it seems appropriate to quote the aphorism: "Clinical experi-
ence is a statistic done carelessly in the head, and in which facts that do not
agree with the preconceived opinion of the experimenter are too easily forgotten,
and those which suit his purpose are overemphasized (2)."
All of us will agree that the great number and variety of incompletely tested
therapeutic agents which have been proposed in the dermatologic literature are
in contrast to the few which were originally tested according to accepted scientific
criteria. Preliminary reports in which the promising therapeutic value of a given
treatment is advanced on the basis of trial in a small uncontrolled series of cases
are interesting. However, the fact is that many of these papers do more harm
than good, in that the quoting and requoting of this type of clinical experience may
lead to the unequivocal acceptance of a method of treatment which essentially
is valueless, and in some cases, harmful. This state of affairs is not limited to
Dermatology. For example, Ross (3) in an excellent article on the "Use of Con-
trols in Medical Research" reported the results of his analysis of 100 unselected
current articles, describing some procedure or therapy for various internal medical
diseases. He concluded that in only 27 per cent of these papers was it demon-
strated that adequate controls were used or that the natural course of the dis-
order was improved by the treatment which was advocated. The articles which
he selected were published in five leading carefully edited medical journals:
J. A. M. A., The American Journal of Medicine, Annals of Internal Medicine,
Archives of Neurology and Psychiatry, and the American Journal of
Medical Sciences.
Unfortunately, some of the problems which confront the clinical investigator
cannot be solved easily. Indeed, it is probable that most of us will agree that it
is more difficult to plan and carry out adequate clinical investigative studies
than to conduct basic laboratory studies of problems relating to the skin.
It is obvious that the clinical investigator has great responsibifities. In con-
trast to the experimental work of a basic scientist, usually his observations
have immediate application in the treatment of diseases in man; an even greater
responsibility is involved in an adequate estimate of the untoward side effects
of a new medicament. Papers dealing with therapeutic studies are apt to be ab-
stracted in numerous medical journals (as well as Time Magazine, and other lay
periodicals), and frequently, are quoted in the advertising literature of pharma-
ceutical houses. Subsequent reports on the same subject by the original investi-
gator, or by others, may disprove the alleged therapeutic efficacy of a given drug
or procedure, or reveal important side-effects which were not apparent during
the initial clinical trials, but unfortunately, this knowledge is not disseminated
through the same channels of information.
Let us consider the qualifications of a successful clinical investigator. It has
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been said that "the quality of clinical investigation begins and ends with men
of high integrity, ability, and inquiry (4)." The clinical scientist must be a
properly trained clinician, but clinical training alone will not make the man a
researcher. In addition, his training must include tutelage in the use of controls
and the planning of experiments. He must learn about the variability of biological
measurements and the proper interpretation of observations. He must be self
critical and objective in his approach.
It is not necessary for me to emphasize to this group that special knowledge of
experimental physiology, microbiology, biochemistry, physics or pathology is a
tremendous asset for the clinical investigator. There is the added factor that a
period of training in a nonclinical department is helpful in learning the discipline
of scientific methods and planning which are not only applicable but absolutely
essential in clinical experimental work.
Those of us who have not had extensive training in one or more of the basic
science disciplines may work in partnership with the bacteriologist, biochemist,
histologist, physiologist and physicist. Personal experience with several such
successful team projects which we have been able to establish with basic science
departments at the University of Texas School of Medicine* and the Henry Ford
Hospital leads me to believe that this approach can be satisfactory and rewarding
for both the basic scientist and the clinician. At the same time, it must be em-
phasized that good clinical research cannot be carried out by merely arranging
for a series of tests to be done in a routine clinical laboratory or any of the various
other special departments in the hospital.
A successful clinical investigative study must be planned so that the design of
the experiment will make certain that the maximum information is obtained with
a minimum of effort. The beginner as well as the experienced clinical investigator
should not embark on any project without preparing an outline of the factors
which may produce a result and the possible answers which experimental ap-
proach will yield. One of the many pitfalls to avoid in planning a clinical in-
vestigative project is an attempt to evaluate several variables in the same
experiment.
The body of knowledge available to medical investigators has increased to such
an extent that many problems can be solved only by the collaboration of experts
from a variety of fields. In a few institutions with unusual facilities for dermato-
logic research, at least several fields of special interest may be represented, and
it is possible for the entire group to assist each other in planning and carrying
out both basic and clinical experimental work. Under other circumstances, it is
essential for the clinical investigator to consult specialists in the basic sciences
and in the clinical specialties. Recently, in conducting one clinical study (5), we
found it rewarding and indeed mandatory to have the advice and/or the active
collaboration of an endocrinologist, a chemist, an internist with special interest
in water balance, and a dietitian.
* In particular, we are indebted to Dr. Charles Pomerat, Chief of the Tissue Culture
Laboratory, and Dr. Frank Engley, Jr., Associate Professor of Bacteriology, University of
Texas School of Medicine.
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One of the basic prerequisites in clinical research is the utilization of adequate
controls. The classic paper on this subject in the dermatologic literature is that
of Pillsbury and his collaborators (6); it was presented at a meeting of this
Society. The important factors which contribute to the planning and adequate
control of clinical investigative projects involving evaluation of methods of
treatment are discussed in a most lucid and authoritative manner. Those of you
who have not read this paper will find it a rewarding experience to do so.
Dermatologists are indebted to Sulzberger and his group, and to Siemens for
their excellent studies on the evaluation of topical medicaments by the so-called
paired comparison method. Their work in this field has stimulated others to
use this approach in conducting clinical investigation involving the evaluation
of local therapy. Under appropriate circumstances, this method of evaluating
local treatment yields valid conclusions. However, the paired comparison method
is not applicable unless involvement is bilateral and equal in severity and the
lesions in the same stage of development. The patient must follow directions
implicitly, a circumstance which may or may not materialize.
Another method of controlling local therapy is to alternate the use of the
control ointment or lotion vehicle with the medicament which is to be evaluated;
the control may be applied for a few days to one week and the results carefully
evaluated; following this, the active medicament is substituted for the control
preparation without the knowledge of the patient; or the process may be reversed
using the active medicament initially, followed by the control. It is necessary
that the control preparation and the topical medicament under investigation
have the same appearance; such a study is more accurate if the investigator does
not identify the control and the active preparation until the results have been
tabulated at the end of the experiment.
It is difficult to subject the appraisal of drugs orally and parenterally adminis-
tered to vigorous control. The fact is that man resists being controlled. Labora-
tory experiments involving the in vitro effect of an antibiotic on bacteria growing
in the test tube is reproducible and predictable, because it depends only on the
bacteriostatic and bactericidal effect of the agent which is in contact with the
bacteria. The therapeutic result when the same antibiotic is used for the local or
systemic treatment of an infected skin lesion is not necessarily predictable or
reproducible, because the effect of the antibiotic on the bacteria may be modified
by numerous other forces acting on the end organ at the same time. Furthermore,
the investigator is just as human as the subject; he may unconsciously affect the
experimental result because of his natural desire for a successful outcome of the
experiment; he may be too enthusiastic, an attribute which may make him a good
psychotherapist but not an objective clinical investigator.
Some of the factors which must be considered in planning a controlled clinical
study when we wish to evaluate an orally or parenterally administered thera-
peutic agent include the sex, age, economic status, occupation, severity of the
disease, and the presence or absence of complications. For example, one funda-
mental consideration in conducting a valid controlled therapeutic study of two
samples of patients with herpes zoster is the age factor.
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The results of therapeutic studies are far more significant if two appropriate
samples of patients are selected, one group treated with a placebo and the other
treated with the drug under investigation. The appearance of the placebo and the
active drug must be identical; the clinical investigator should not identify the
active and the inactive preparations until the end of the experiment. However,
even the intelligent use of placebos does not settle the questions which are in-
volved in some therapeutic studies. In a most important paper relating to the
pharmacology of placebos, Wolf (7) has shown that the effect of drugs must be
assessed "not only with reference to their pharmacologic action, but also to the
other forces at play and to the circumstances surrounding their administration."
He had the opportunity to observe the effects of various drugs as well as placebos
on the gastric mucosa of a human subject who had a large gastric fistula. In his
extensive study of this patient, the following factors appeared to be of leading
importance in influencing the effects of the drugs and placebos which were in-
vestigated: "(1) The state of the end organ at the time of administration, i.e.,
the effects of forces already acting prior to the administration of the agent;
(2) The setting in which the agent was administered, including the route of
administration, the presence of the experimenter and the effect of suggestion,
implicit or expressed; (3) Conditioning circumstances and previously established
habits of reaction."
The habit of quantitative and statistical thought is essential in clinical research.
As Mainland (8) has emphasized in an excellent paper on this subject, statistical
ideas must be considered in the early planning of a project, because statistical
methods cannot be applied to data which have been collected in an experiment
which was not planned and conducted correctly. The clinical investigator must
be familiar with the elementary general principles of statistics as they apply to
clinical research. He must understand the requirements of adequate samples of
patients, the principle of random sampling, the influence of chance variations,
and the meaning of statistical significance.
Training and experience in the use of clinical research methods are essential in
developing specialists in Dermatology. In a department dominated by a spirit of
inquiry, the beginner in Dermatology learns to appreciate the imperfections and
inconsistencies of the established body of knowledge and he develops a dominant
ambition to acquire new knowledge. The opportunity for the resident or fellow to
do clinical research during his training period has a profound influence in im-
proving the quality of his observations in his daily contact with patients, without
which good practice is impossible.
I have in a sketchy manner re-emphasized some of the basic principles as well
as the problems which are involved in clinical investigative studies. It is not
necessary to apologize for presenting a paper related to clinical research at a
meeting of this Society. The final test of knowledge acquired in basic studies in
the laboratory and in animal research is its application to the patient. Further-
more, the answer to some of our problems are probably as simple as was the liver
treatment of pernicious anemia.
I have not attempted to compare the relative importance of basic and clinical
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investigation. The meetings of this group should serve as a forum for the presenta-
tion of both basic research and clinical investigation. I think that it is unfortunate
that during recent years, the programs of this Society have included compara-
tively few papers relating to clinical investigation. In discussing this with some of
my colleagues, I have the impression that many dermatologists hesitate to submit
clinical investigative papers for the program of this Society. I hope that there is a
reversal of this trend. The policy of inchiding a representative number of clinical
investigative papers on this program would foster a closer collaboration between
clinicians and basic science laboratory workers, a circumstance which is not only
desirable but essential. Furthermore, under these circumstances, our meetings
would attract the interest of more dermatologists.
Clinical investigation has had an important role in the development of our
specialty. Clinical dermatologists as a group have the spirit of inquiry. They
have used the laboratory when it is applicable to the problem at hand—recall the
work which has been done by some of our colleagues in the field of fungus in-
fections. Some of the future advances in our specialty will continue to be made by
clinical researchers. This Society should have a part in this, and it could be done
by encouraging the presentation of a representative number of papers dealing
with clinical investigation at these meetings.
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